Semaglutide is effective in achieving weight loss in liver transplant recipients

By sjmartinez • January 22, 2024

Chow KW, Ibrahim B, Rahal K, Hsu RH, Tan T, Meneses K, Saab S. Semaglutide is effective in achieving weight loss in liver transplant recipients. Liver Transpl. 2024 Feb 1;30(2):223-225. doi: 10.1097/LVT.0000000000000247. Epub 2023 Aug 29. PMID: 37639288.

Tags: Digestive Diseases, General Internal Medicine, Harbor UCLA, Publications

Related Posts

The 2024 top 10 list of endoscopy topics in medical publishing: an annual review by the American Society for Gastrointestinal Endoscopy Editorial Board

Martinez M, Bartel MJ, Chua T, Dakhoul L, Fatima H, Glessing B, Jensen D, Lara LF, Shinn B, Tadros M, Villa E, Saltzman JR. The[...]

Fidaxomicin reduces collagen expression in intestinal fibroblasts via platelet-derived growth factor receptor beta and glycogen synthase kinase-3 beta inhibition

Irwin S, van Daelen M, Almaraz I, Park R, Nelson B, Mahurkar-Joshi S, Rieder F, Shih DQ, Ho W, Limketkai B, Koon HW. Fidaxomicin reduces[...]

Social Determinants of Health are Associated with Liver Transplant Evaluation and Listing in a Safety-Net Referral Cohort

Bangaru S, Wang MC, Sumethasorn M, Wang S, Wong C, Omer S, Kim N, Shah S, Yilma M, Tana M, Mehta N, Benhammou JN, Zhou[...]